全文获取类型
收费全文 | 15373篇 |
免费 | 2664篇 |
国内免费 | 1909篇 |
专业分类
化学 | 11328篇 |
晶体学 | 227篇 |
力学 | 862篇 |
综合类 | 147篇 |
数学 | 1613篇 |
物理学 | 5769篇 |
出版年
2024年 | 63篇 |
2023年 | 318篇 |
2022年 | 563篇 |
2021年 | 563篇 |
2020年 | 589篇 |
2019年 | 652篇 |
2018年 | 526篇 |
2017年 | 510篇 |
2016年 | 719篇 |
2015年 | 734篇 |
2014年 | 933篇 |
2013年 | 1232篇 |
2012年 | 1431篇 |
2011年 | 1547篇 |
2010年 | 1038篇 |
2009年 | 1010篇 |
2008年 | 1015篇 |
2007年 | 990篇 |
2006年 | 800篇 |
2005年 | 683篇 |
2004年 | 580篇 |
2003年 | 443篇 |
2002年 | 414篇 |
2001年 | 350篇 |
2000年 | 328篇 |
1999年 | 252篇 |
1998年 | 218篇 |
1997年 | 170篇 |
1996年 | 185篇 |
1995年 | 148篇 |
1994年 | 157篇 |
1993年 | 118篇 |
1992年 | 115篇 |
1991年 | 94篇 |
1990年 | 87篇 |
1989年 | 77篇 |
1988年 | 44篇 |
1987年 | 41篇 |
1986年 | 42篇 |
1985年 | 40篇 |
1984年 | 29篇 |
1983年 | 16篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1980年 | 6篇 |
1979年 | 11篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1957年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
251.
采用盆栽试验研究了Nd3 在不同诱导时间对番茄叶抗性指标(过氧化物酶(POD)、多酚氧化酶(PPO)和苯丙氨酸解氨酶(PAL)活性、细胞膜透性、氧自由基(O2-·)产生速率和木质素含量)的影响.结果表明:从第3 d开始,Nd3 诱导提高番茄叶内PAL活性,第3d增幅也最大,达32.30%,维持时间为诱导后第3~5 d;Nd3 诱导后第1~2 d POD活性升高,第1 d增幅最大,维持时间是诱导后第1~2 d;Nd3 诱导后1~3 d,PPO活性升高,第1 d增幅最大,维持时间是诱导后第1~3 d;从诱导后第2 d开始,Nd3 降低细胞膜透性,第3 d时降幅最大,为54.33%,持续时间为诱导后第2~5 d;从第3 d开始,Nd3 诱导降低氧自由基产生速率,第4 d降幅最大,第3 d氧自由基产生速率最低,持续时间为诱导后第3~5 d;从第4 d开始,Nd3 诱导提高木质素含量,5 d时有继续升高的趋势.从不同诱导时间番茄叶PAL活性、细胞膜透性、氧自由基产生速率的变化来看,在Nd3 诱导的第3 d,番茄产生的抗性最强. 相似文献
252.
253.
本实验运用一阶导数差示脉冲极谱法对甲硝唑及其制剂进行了定量研究。在0.001mol/L氯化钾-0.001mol/L盐酸-水(1+0.2+48)的底液中,甲硝唑于-0.800V(vs Ag/AgCl)处出现一良好的一阶导数差示脉冲极谱峰,在50~300μg/mL范围内,药物浓度与其导数峰幅值呈线关系,检测限为8.0×10^-8mol/L。本法操作简便,快速,灵敏,结果准确。 相似文献
254.
1—酰基—4—氯环己烷与取代芳烃的区域与立体选择性反应 总被引:2,自引:0,他引:2
从环己烯合成了1-酰基-4-氯环己烷,发现在其在AlCl3催化与苯,氯苯,溴苯等优先生成反式1-芳基-4-酰基环己烷,与联苯反应时选择性较差。 相似文献
255.
Yechen Hu Zhongcheng Wang Liang Liu Jianhua Zhu Dongxue Zhang Mengying Xu Yuanyuan Zhang Feifei Xu Yun Chen 《Chemical science》2021,12(23):7993
Precision medicine has been strongly promoted in recent years. It is used in clinical management for classifying diseases at the molecular level and for selecting the most appropriate drugs or treatments to maximize efficacy and minimize adverse effects. In precision medicine, an in-depth molecular understanding of diseases is of great importance. Therefore, in the last few years, much attention has been given to translating data generated at the molecular level into clinically relevant information. However, current developments in this field lack orderly implementation. For example, high-quality chemical research is not well integrated into clinical practice, especially in the early phase, leading to a lack of understanding in the clinic of the chemistry underlying diseases. In recent years, mass spectrometry (MS) has enabled significant innovations and advances in chemical research. As reported, this technique has shown promise in chemical mapping and profiling for answering “what”, “where”, “how many” and “whose” chemicals underlie the clinical phenotypes, which are assessed by biochemical profiling, MS imaging, molecular targeting and probing, biomarker grading disease classification, etc. These features can potentially enhance the precision of disease diagnosis, monitoring and treatment and thus further transform medicine. For instance, comprehensive MS-based biochemical profiling of ovarian tumors was performed, and the results revealed a number of molecular insights into the pathways and processes that drive ovarian cancer biology and the ways that these pathways are altered in correspondence with clinical phenotypes. Another study demonstrated that quantitative biomarker mapping can be predictive of responses to immunotherapy and of survival in the supposedly homogeneous group of breast cancer patients, allowing for stratification of patients. In this context, our article attempts to provide an overview of MS-based chemical mapping and profiling, and a perspective on their clinical utility to improve the molecular understanding of diseases for advancing precision medicine.An overview of MS-based chemical mapping and profiling, indicating its contributions to the molecular understanding of diseases in precision medicine by answering "what", "where", "how many" and "whose” chemicals underlying clinical phenotypes. 相似文献
256.
Flow-injection chemiluminescence determination of fluoroquinolones by enhancement of weak chemiluminescence from peroxynitrous acid 总被引:1,自引:0,他引:1
A flow-injection chemiluminescence (CL) method is described for the determination of fluoroquinolones including ciprofloxacin, norfloxacin and ofloxacin. The method is based on the enhancement by these compounds of the weak CL from peroxynitrous acid. The linear ranges are 1.0×10−7 to 1.0×10−5 mol l−1 for ciprofloxacin and norfloxacin, and 3.0×10−7 to 3.0×10−5 mol l−1 for ofloxacin, respectively. The detection limits (S/N=3) are 4.5×10−8 mol l−1 ciprofloxacin, 5.9×10−8 mol l−1 norfloxacin and 1.1×10−7 mol l−1 ofloxacin, respectively. The proposed method was applied to the determination of fluoroquinolones in pharmaceutical preparations. 相似文献
257.
讨论了沸点升高法测定混和溶剂化热和汽化熵的原理,并用拟静态法测定了乙醇-丙酮,并-四氯化碳和苯,甲苯三组混和溶剂在不同组成下的正常沸点,根据沸点数据求得了混和泶微分汽化热和汽化熵,实验结果表明,二元混和溶剂与理想溶液偏离不大时,其正常汽化熵符合Trouton规则。 相似文献
258.
Feedings of [1-13C]- and [1,2-13C2]acetate Aspergillus terreus gave quadrone and terrecyclic acid which were analyzed by 13C NMR. The pattern of 13C-enrichments and couplings is consistent with the formation of 1 and 2 by cyclization of farnesyl pyrophosphate. 相似文献
259.
Moriarty RM Rani N Enache LA Rao MS Batra H Guo L Penmasta RA Staszewski JP Tuladhar SM Prakash O Crich D Hirtopeanu A Gilardi R 《The Journal of organic chemistry》2004,69(6):1890-1902
A general and novel solution to the synthesis of biologically important stable analogues of prostacyclin PGI(2), namely benzindene prostacyclins, has been achieved via the stereoselective intramolecular Pauson-Khand cyclization (PKC). This work illustrates for the first time the synthetic utility and reliability of the asymmetric PKC route for synthesis and subsequent manufacture of a complex drug substance on a multikilogram scale. The synthetic route surmounts issues of individual step stereoselectivity and scalability. The key step in the synthesis involves efficient stereoselection effected in the PKC of a benzoenyne under the agency of the benzylic OTBDMS group, which serves as a temporary stereodirecting group that is conveniently removed via benzylic hydrogenolysis concomitantly with the catalytic hydrogenation of the enone PKC product. Thus the benzylic chiral center dictates the subsequent stereochemistry of the stereogenic centers at three carbon atoms (C(3a), C(9a), and C(1)). 相似文献
260.